English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 907587 Online Users : 967
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
癌症研究所
陳立宗
--期刊論文
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
國家衛生研究院 NHRI
>
癌症研究所
>
陳立宗
>
期刊論文
>
Browse By Title
Browse By Authors
Browse By Date
Browse By Data Type
Loading...
Siblings
圖書
[
1
/1]
會議論文/會議摘要
[
115
/179]
Collection Statistics
近3年內發表的文件:58(17.58%)
含全文筆數:327(99.09%)
文件下載次數統計
下載大於0次:327(100.00%)
下載大於100次:313(95.72%)
檔案下載總次數:138442(77.76%)
最後更新時間: 2024-12-01 00:11
Top Upload
Loading...
Top Download
Loading...
Recent Submissions
Pan-Asian adapted ESMO clinical pra...
Nivolumab plus chemotherapy in pati...
Survival of advanced/recurrent gast...
Topiramate suppresses peri-infarct ...
A phase 1 study of biweekly nab-pac...
Plain language summary of the FOENI...
Outcomes of post-immunotherapy dura...
Durvalumab or placebo plus gemcitab...
Impact of previous S-1 treatment on...
Chromatin remodeling-related PRDM1 ...
Jump to a point in the index:
(Choose year)
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(Choose month)
January
February
March
April
May
June
July
August
September
October
November
December
Or type in a year:
Ordering With Most Recent First
Show Oldest First
Showing items 101-125 of 330. (14 Page(s) Totally)
<<
<
1
2
3
4
5
6
7
8
9
10
>
>>
View [
10
|
25
|
50
] records per page
Date
Title
Relation
2019-12
Identification of a multitargeted tyrosine kinase inhibitor for the treatment of gastrointestinal stromal tumors and acute myeloid leukemia
Journal of Medicinal Chemistry. 2019 Dec;62(24):11135-11150.
2019-11-27
Characterization of a fiber bundle-based real-time ultrasound/photoacoustic imaging system and its in vivo functional imaging applications
Micromachines. 2019 Nov 27;10(12):Article number 820.
2019-10
The epidemiology of gastric cancers in the era of Helicobacter pylori eradication: A nation-wide cancer registry-based study in Taiwan
Cancer Epidemiology, Biomarkers and Prevention. 2019 Oct;28(10):1694-1703.
2019-10
A randomized controlled, open label, adaptive phase III Trial to evaluate safety and efficacy of endoTAG-1 plus gemcitabine versus gemcitabine alone in patients with measurable locally advanced and/or metastatic adenocarcinoma of the pancreas failed on FO
Annals of Oncology. 2019 Oct;30(Suppl. 5):321.
2019-09
Nuclear KIT induces a NFKBIB-RELA-KIT autoregulatory loop in imatinib-resistant gastrointestinal stromal tumors
Oncogene. 2019 Aug;38:6550-6565.
2019-09
Pancreatic stellate cells activated by mutant KRAS-mediated PAI-1 upregulation foster pancreatic cancer progression via IL-8
Theranostics. 2019 Sep. 23;9(24):7168-7183.
2019-07-28
Nomogram for predicting survival in patients treated with liposomal irinotecan plus fluorouracil and leucovorin in metastatic pancreatic cancer
Cancers. 2019 Jul 28;11(8):Article number 1068.
2019-07
Preventive hypothermia as a neuroprotective strategy for paclitaxel-induced peripheral neuropathy
Pain. 2019 Jul;160(7):1505-1521.
2019-07
Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer
Journal of Hematology and Oncology. 2019 Jul;12:Article number 79.
2019-06-24
Alteration of epigenetic modifiers in pancreatic cancer and its clinical implication
Journal of Clinical Medicine. 2019 Jun 24;8(6):Article number 903.
2019-06-21
Identification of phenothiazine as an ETV1targeting agent in gastrointestinal stromal tumors using the Connectivity Map
International Journal of Oncology. 2019 Jun 21;55(2):536-546.
2019-06
Emergence of RAS mutations in patients with metastatic colorectal cancer receiving cetuximab-based treatment: A study protocol
BMC Cancer. 2019 Jun;19:Article number 640.
2019-05-27
Deciphering the potential role of hox genes in pancreatic cancer
Cancers. 2019 May 27;11(5):Article number 734.
2019-05-20
Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer
Molecular Cancer. 2019 May 20;18:Article number 96.
2019-05
Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer - A subgroup analysis of the pivotal NAPOLI-1 trial
Journal of Geriatric Oncology. 2019 May;10(3):427-435.
2019-04-17
Novel insights of lymphomagenesis of helicobacter pylori-dependent gastric mucosa-associated lymphoid tissue lymphoma
Cancers. 2019 Apr 17;11(4):Article number 547.
2019-04-10
Discovery of Conformational Control Inhibitors Switching off the Activated c-KIT and Targeting a Broad Range of Clinically Relevant c-KIT Mutants
Journal of Medicinal Chemistry. 2019 Apr 10;62(8):3940-3957.
2019-04-08
Predominant global glomerulosclerosis in patients of upper urinary tract urothelial carcinoma with pre-existing renal function impairment is a predictor of poor renal outcomes
BMC Cancer. 2019 Apr 8;19:Article number 337.
2019-03
A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens
Gastric Cancer. 2019 Mar;22(2):344-354.
2019-03
Foreword
Hepatobiliary Surgery and Nutrition. 2019 Mar;8(Suppl. 1):S1.
2019-02
ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling
Oncogene. 2019 Feb;38(8):1340-1353.
2019-02
ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling [Erratum: Oncogene. 2019 Feb;38(8):1340-1353.]
Oncogene. 2019 Feb;38(8):1354.
2019-02
Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: Interim results of a randomized, phase II trial (attraction-4)
Annals of Oncology. 2019 Feb;30(2):250-258.
2019-02
NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors
European Journal of Cancer. 2019 Feb;108:78-87.
2019-01
Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorin
European Journal of Cancer. 2019 Jan;106:24-33.
Showing items 101-125 of 330. (14 Page(s) Totally)
<<
<
1
2
3
4
5
6
7
8
9
10
>
>>
View [
10
|
25
|
50
] records per page
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
Feedback